Although the mechanisms for how high expression of p62 in tumor cells causes shorter survival remain unknown, our results suggest a need for ongoing and future clinical investigations of autophagy inhibitors to monitor p62 levels in PDAC tumor cells, as too high levels may be devastating for patients. The gene discussed is SQSTM1; the disease is neoplasm.